BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 12534642)

  • 1. Polymorphisms in the cytochrome P450 CYP1A2 gene (CYP1A2) in colorectal cancer patients and controls: allele frequencies, linkage disequilibrium and influence on caffeine metabolism.
    Sachse C; Bhambra U; Smith G; Lightfoot TJ; Barrett JH; Scollay J; Garner RC; Boobis AR; Wolf CR; Gooderham NJ;
    Br J Clin Pharmacol; 2003 Jan; 55(1):68-76. PubMed ID: 12534642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The G-113A polymorphism in CYP1A2 affects the caffeine metabolic ratio in a Chinese population.
    Chen X; Wang L; Zhi L; Zhou G; Wang H; Zhang X; Hao B; Zhu Y; Cheng Z; He F
    Clin Pharmacol Ther; 2005 Sep; 78(3):249-59. PubMed ID: 16153396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of the genetic polymorphism in the 5'-noncoding region of the CYP1A2 gene on CYP1A2 phenotype and urinary mutagenicity in smokers.
    Pavanello S; Pulliero A; Lupi S; Gregorio P; Clonfero E
    Mutat Res; 2005 Nov; 587(1-2):59-66. PubMed ID: 16188490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphism of CYP1A2 in Ethiopians affecting induction and expression: characterization of novel haplotypes with single-nucleotide polymorphisms in intron 1.
    Aklillu E; Carrillo JA; Makonnen E; Hellman K; Pitarque M; Bertilsson L; Ingelman-Sundberg M
    Mol Pharmacol; 2003 Sep; 64(3):659-69. PubMed ID: 12920202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast Cancer Association with CYP1A2 Activity and Gene Polymorphisms--a Preliminary Case-control Study in Tunisia.
    Imene A; Maurice AJ; Arij M; Sofia P; Saad S
    Asian Pac J Cancer Prev; 2015; 16(8):3559-63. PubMed ID: 25921178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of -3858G-->A and -164C-->A genetic polymorphisms of CYP1A2 in blood and saliva by rapid allelic discrimination: large difference in the prevalence of the -3858G-->A mutation between Caucasians and Asians.
    Todesco L; Török M; Krähenbühl S; Wenk M
    Eur J Clin Pharmacol; 2003 Aug; 59(4):343-6. PubMed ID: 12851801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid genotyping for relevant CYP1A2 alleles by pyrosequencing.
    Skarke C; Kirchhof A; Geisslinger G; Lötsch J
    Eur J Clin Pharmacol; 2005 Dec; 61(12):887-92. PubMed ID: 16307269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quercetin significantly inhibits the metabolism of caffeine, a substrate of cytochrome P450 1A2 unrelated to CYP1A2*1C  (-2964G>A) and *1F (734C>A) gene polymorphisms.
    Xiao J; Huang WH; Peng JB; Tan ZR; Ou-Yang DS; Hu DL; Zhang W; Chen Y
    Biomed Res Int; 2014; 2014():405071. PubMed ID: 25025048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CYP1A2-164A-->C polymorphism (CYP1A2*1F) is associated with the risk for colorectal adenomas in humans.
    Moonen H; Engels L; Kleinjans J; Kok Td
    Cancer Lett; 2005 Nov; 229(1):25-31. PubMed ID: 16157215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparisons of CYP1A2 genetic polymorphisms, enzyme activity and the genotype-phenotype relationship in Swedes and Koreans.
    Ghotbi R; Christensen M; Roh HK; Ingelman-Sundberg M; Aklillu E; Bertilsson L
    Eur J Clin Pharmacol; 2007 Jun; 63(6):537-46. PubMed ID: 17370067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haplotypes in the 5'-untranslated region of the CYP1A2 gene are inversely associated with lung cancer risk but do not correlate with caffeine metabolism.
    Gervasini G; Ghotbi R; Aklillu E; San Jose C; Cabanillas A; Kishikawa J; Benitez J; Carrillo JA
    Environ Mol Mutagen; 2013 Mar; 54(2):124-32. PubMed ID: 23138776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of CYP1A2 gene polymorphisms on Theophylline metabolism and chronic obstructive pulmonary disease in Turkish patients.
    Uslu A; Ogus C; Ozdemir T; Bilgen T; Tosun O; Keser I
    BMB Rep; 2010 Aug; 43(8):530-4. PubMed ID: 20797314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotyping of four genetic polymorphisms in the CYP1A2 gene in the Egyptian population.
    Hamdy SI; Hiratsuka M; Narahara K; Endo N; El-Enany M; Moursi N; Ahmed MS; Mizugaki M
    Br J Clin Pharmacol; 2003 Mar; 55(3):321-4. PubMed ID: 12630986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms of cytochrome P4501A2 and N-acetyltransferase genes, smoking, and risk of pancreatic cancer.
    Li D; Jiao L; Li Y; Doll MA; Hein DW; Bondy ML; Evans DB; Wolff RA; Lenzi R; Pisters PW; Abbruzzese JL; Hassan MM
    Carcinogenesis; 2006 Jan; 27(1):103-11. PubMed ID: 15987714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between common CYP1A2 polymorphisms and theophylline metabolism in non-smoking healthy volunteers.
    Wang L; Hu Z; Deng X; Wang Y; Zhang Z; Cheng ZN
    Basic Clin Pharmacol Toxicol; 2013 Apr; 112(4):257-63. PubMed ID: 23167834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic polymorphisms of cytochrome P450-1A2 (CYP1A2) among Emiratis.
    Al-Ahmad MM; Amir N; Dhanasekaran S; John A; Abdulrazzaq YM; Ali BR; Bastaki SMA
    PLoS One; 2017; 12(9):e0183424. PubMed ID: 28934216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between caffeine and polymorphisms of glutamate ionotropic receptor NMDA type subunit 2A (GRIN2A) and cytochrome P450 1A2 (CYP1A2) on Parkinson's disease risk.
    Kim IY; O'Reilly ÉJ; Hughes KC; Gao X; Schwarzschild MA; McCullough ML; Hannan MT; Betensky RA; Ascherio A
    Mov Disord; 2018 Mar; 33(3):414-420. PubMed ID: 29318639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inducibility of CYP1A2 by omeprazole in vivo related to the genetic polymorphism of CYP1A2.
    Han XM; Ouyang DS; Chen XP; Shu Y; Jiang CH; Tan ZR; Zhou HH
    Br J Clin Pharmacol; 2002 Nov; 54(5):540-3. PubMed ID: 12445035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CYP1A2*1D and *1F polymorphisms have a significant impact on olanzapine serum concentrations.
    Czerwensky F; Leucht S; Steimer W
    Ther Drug Monit; 2015 Apr; 37(2):152-60. PubMed ID: 25090458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic polymorphisms in heterocyclic amine metabolism and risk of colorectal adenomas.
    Ishibe N; Sinha R; Hein DW; Kulldorff M; Strickland P; Fretland AJ; Chow WH; Kadlubar FF; Lang NP; Rothman N
    Pharmacogenetics; 2002 Mar; 12(2):145-50. PubMed ID: 11875368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.